Skip to content

DR. STEFAAN DEWULF

Active
Private limited companyfounded 200323 yrs activeSamuel Morselaan 9, 1780 Wemmel, BelgiumKBO/BCE: BE 0479.588.982
Summary

DR. STEFAAN DEWULF has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €412k and a net result of €-64k. Equity is shrinking by ~9.5% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 1.2% (low).

Checked score

Score 2025
56 / 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability3▼-89
Solvency100=
Growth32=
Track record100
Bankruptcy probability, 12 months
1.2% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €23k at 30 days acceptable
Liquidity ample (current ratio 4.82 against 5.73 in 2024; short-term debt: 18.9% and cash: 5.1% of total assets), and 19.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 23 years 0 30 y
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
9 d early
2024
1 d early
2023
5 d early
2022
11 d early
2021
4 d early
2020
9 d late
2019
104 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€412k▼ 13.4%
2024 · €476k
2018: €907k 2019: €849k 2020: €710k 2021: €806k 2022: €755k 2023: €576k 2024: €476k
2018 → 2025
Total assets
€510k▼ 9.7%
2024 · €564k
2018: €1.09M 2019: €1.12M 2020: €909k 2021: €951k 2022: €811k 2023: €620k 2024: €564k
2018 → 2025
Net result
€-64k
2024 · €105k
2018: €170k 2019: €27k 2020: €-139k 2021: €96k 2022: €-51k 2023: €21k 2024: €105k
2018 → 2025
Working capital
€367k▼ 12.1%
2024 · €418k
2018: €746k 2019: €711k 2020: €594k 2021: €711k 2022: €588k 2023: €424k 2024: €418k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€806k-€755k▼ 6.4%€576k▼ 23.7%€476k▼ 17.4%€412k▼ 13.4%
Operating result€78k-€-32k€11k€17k▲ 55.5%€-60k
Net result€96k-€-51k€21k€105k▲ 395%€-64k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-100k€-50k€0€50k€100kOperating result 2021: €78k€78kNet result 2021: €96k€96kOperating result 2022: €-32k€-32kNet result 2022: €-51k€-51kOperating result 2023: €11k€11kNet result 2023: €21k€21kOperating result 2024: €17k€17kNet result 2024: €105k€105kOperating result 2025: €-60k€-60kNet result 2025: €-64k€-64k20212022202320242025€-100k€-50k€0€50k€100kOperating result 2023: €11k€11kNet result 2023: €21k€21kOperating result 2024: €17k€17kNet result 2024: €105k€105kOperating result 2025: €-60k€-60kNet result 2025: €-64k€-64k202320242025
The operating result turns negative in 2025: a loss of €60k after €17k in 2024, the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €510k
Fixed assets €46k ▼ 20.8%
Current assets €463k ▼ 8.4%
Equity and liabilities €510k
Equity €412k ▼ 13.4%
Debt €97k ▲ 10.3%
Debt's share of the balance-sheet total rises from 15.6% to 19.1%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€-48k
2024 · €29k
Cash flow
€-52k
2024 · €117k
Current ratio
4.82
2024 · 5.73
Debt to equity
0.24
2024 · 0.19
ROE
-15.5%
2024 · 22.0%
ROA
-12.6%
2024 · 18.6%
Interest coverage
-470.42
2024 · 16.28
Debt ≤ 1 year
€96k
2024 · €88k
Income taxes
€11k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet Code20242025
Assets
Total assets20/58€564k€510k
Fixed assets21/28€59k€46k
Tangible fixed assets22/27€59k€46k
Land and buildings22€57k€45k
Furniture and vehicles24€2k€1k
Other tangible fixed assets26-€238
Current assets29/58€506k€463k
Amounts receivable within one year40/41€7k€6k
Trade receivables40€3k€4k
Other amounts receivable41€4k€2k
Current investments50/53€487k€431k
Cash at bank and in hand54/58€11k€26k
Deferred charges and accrued income490/1€80€151
Equity and liabilities
Total equity and liabilities10/49€564k€510k
Equity10/15€476k€412k
Contributions10/11€19k€19k=
Reserves13€445k€445k=
Distributable reserves133€445k€445k=
Profit (loss) carried forward14€13k€-51k
Amounts payable17/49€88k€97k
Amounts payable within one year42/48€88k€96k
Trade debts44€9k€5k
Suppliers440/4€9k€5k
Taxes, remuneration and social security45-€10k
Taxes450/3-€10k
Other amounts payable47/48€80k€80k
Accrued charges and deferred income492/3-€1k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€12k
Other operating charges640/8€5k€1k
Gross operating margin9900€34k€-46k
Operating profit (loss)9901€17k€-60k
Financial income75/76B€90k€6k
Recurring financial income75€22k€6k
Non-recurring financial income76B€68k-
Financial charges65/66B€2k€101
Recurring financial charges65€2k€101
Profit (loss) for the period before taxes9903€105k€-53k
Income taxes67/77-€11k
Profit (loss) for the period9904€105k€-64k
Profit (loss) for the period to be appropriated9905€105k€-64k
Appropriation of the result
Profit (loss) to be appropriated9906€218k€-51k
Profit (loss) brought forward from the previous period14P€113k€13k
Profit to be distributed694/7€205k-
Return on contributions (dividend)694€205k-

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
22-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
30-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
26-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Back to profitnet €21k
Net result €21k after one loss-making year.
20-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
27-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Back to profitnet €96k
Net result €96k after one loss-making year.
31-12
Financial Liquidity doublescurrent ratio 13.79
Current ratio from 6.42 to 13.79; short-term debt falls from €109k to €56k.
09-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 9 days late
2020
31-12
Financial Weakest financial yearnet €-139k ▼612%
Net result drops to €-139k, the lowest in the series; recovery starts the following year.
12-11
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 104 days late
2019
09-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 9 days late
2018
09-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 9 days late
2017
10-08
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 10 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wemmel · 2 establishment units since 2003
establishment All 2 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Samuel Morselaan 91780 Wemmel
Ground area
1,045 m²
Building footprint
205 m²
Volume, LiDAR
1,405 m³
2 parcels, Flanders · tallest building 9.8 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
Samuel Morselaan 9, 1780 Wemmel
NACE 85141
since 20032.229.041.390
Maatschap Medische Beeldvorming
Brusselsestraat 94, 1840 LonderzeelNACE 85141
since 20032.303.369.819
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
22005A0049/00M000 Flanders 806 m² 1 · 120 m² 8.6 m · 2 fl.
23045E0355/00T003 Flanders 239 m² 1 · 85 m² 9.8 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

875500LMQ0B1KPLRRK42
live in the LEI register

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded19-02-2003
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 21 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.